- Home
- TEVA vs LI Comparison
TEVA vs LI Comparison
Compare TEVA & LI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TEVA
- LI
- Stock Information
- Founded
- TEVA 1901
- LI 2015
- Country
- TEVA Israel
- LI China
- Employees
- TEVA N/A
- LI N/A
- Industry
- TEVA Biotechnology: Pharmaceutical Preparations
- LI Auto Manufacturing
- Sector
- TEVA Health Care
- LI Consumer Discretionary
- Exchange
- TEVA Nasdaq
- LI Nasdaq
- Market Cap
- TEVA 20.1B
- LI 23.4B
- IPO Year
- TEVA N/A
- LI 2020
- Fundamental
- Price
- TEVA $16.97
- LI $26.01
- Analyst Decision
- TEVA Strong Buy
- LI Buy
- Analyst Count
- TEVA 8
- LI 5
- Target Price
- TEVA $25.00
- LI $31.72
- AVG Volume (30 Days)
- TEVA 11.1M
- LI 3.9M
- Earning Date
- TEVA 07-30-2025
- LI 05-29-2025
- Dividend Yield
- TEVA N/A
- LI N/A
- EPS Growth
- TEVA N/A
- LI N/A
- EPS
- TEVA N/A
- LI 1.05
- Revenue
- TEVA $16,616,000,000.00
- LI $19,948,060,367.00
- Revenue This Year
- TEVA $5.69
- LI $23.04
- Revenue Next Year
- TEVA N/A
- LI $27.91
- P/E Ratio
- TEVA N/A
- LI $24.74
- Revenue Growth
- TEVA 3.82
- LI 10.75
- 52 Week Low
- TEVA $12.47
- LI $17.44
- 52 Week High
- TEVA $22.80
- LI $33.12
- Technical
- Relative Strength Index (RSI)
- TEVA 48.95
- LI 38.30
- Support Level
- TEVA $16.82
- LI $27.64
- Resistance Level
- TEVA $17.73
- LI $28.74
- Average True Range (ATR)
- TEVA 0.55
- LI 0.53
- MACD
- TEVA -0.13
- LI -0.48
- Stochastic Oscillator
- TEVA 25.14
- LI 2.78
About TEVA Teva Pharmaceutical Industries Limited
Teva Pharmaceutical Industries, based in Israel, is the leading generic drug manufacturer in the world. Teva derives half of its sales from North America and makes up a high-single-digit percentage of the total number of generic prescriptions in the US. It also has a significant presence in Europe, Japan, Russia, and Israel. Besides generics, Teva has a portfolio of innovative medicines and biosimilars in three main therapeutic areas: the central nervous system with Copaxone, Ajovy, and Austedo; respiratory with Qvar and ProAir; and oncology with Truxima, Herzuma, and Bendeka/Treanda. Teva also sells active pharmaceutical ingredients, offers contract manufacturing services, and owns Anda, a US-based generic and specialty drug distributor.
About LI Li Auto Inc.
Li Auto is a leading Chinese NEV manufacturer that designs, develops, manufactures, and sells premium smart NEVs. The company started volume production of its first model Li One in November 2019. The model is a six-seater, large, premium plug-in electric SUV equipped with a range extension system and advanced smart vehicle solutions. It sold over 500,000 NEVs in 2024, accounting for about 4% of China's passenger new energy vehicle market. Beyond Li One, the company expands its product line, including both BEVs and PHEVs, to target a broader consumer base.